| Literature DB >> 34964835 |
Yuki Takamatsu1,2, Tomomi Higashide1, Satoshi Takeshima3, Makoto Sasaki1, Yoshimi Manbo4, Sachiko Udagawa1, Shinji Ohkubo1,5, Shozo Sonoda6, Taiji Sakamoto6, Kazuhisa Sugiyama1.
Abstract
Purpose: To elucidate the relationship between changes in the choroidal structure and blood flow of the macula after trabeculectomy.Entities:
Mesh:
Year: 2021 PMID: 34964835 PMCID: PMC8727312 DOI: 10.1167/tvst.10.14.30
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Baseline Patient Characteristics
| Age (Years) | 68.6 ± 8.8 (61 to 73) |
| Sex (male/female, cases) | 11/19 |
| Diagnosis (POAG/XFG, eyes) | 24/6 |
| Systemic hypertension, cases (%) | 15 (50.0) |
| Diabetes mellitus, cases (%) | 1 (3.3) |
| Hyperlipidemia (%) | 4 (13.3) |
| Smokers (%) | 3 (10.0) |
| AL (mm) | 24.1 ± 1.2 (23.3 to 25.2) |
| Spherical equivalent refractive error (diopters) | −2.0 ± 2.3 (−2.8 to −0.4) |
| IOP (mm Hg) | 18.0 ± 4.6 (15 to 20) |
| Mean deviation (dB) | −19.9 ± 5.7 (−24.3 to −14.2) |
| BP (mm Hg) | |
| Systolic BP | 128.7 ± 24.4 (114 to 139) |
| Diastolic BP | 70.6 ± 12.5 (63 to 80) |
| MAP | 90.0 ± 15.7 (80 to 102) |
| OPP (mm Hg) | 42.0 ± 10.7 (34 to 49) |
| Pulse rate (beats/min) | 72.5 ± 11.5 (63 to 82) |
| No. of preoperative antiglaucoma medications (range) | 4.2 ± 0.8 (4 to 6) |
| Prostaglandin analogues (%) | 30 (100) |
| β-Antagonists (%) | 28 (93.3) |
| Carbonic anhydrase inhibitors (%) | 27 (90.0) |
| α-1 Antagonist (bunazosin, %) | 10 (33.3) |
| α-2 Agonist (brimonidine, %) | 24 (80.0) |
| Rho kinase inhibitor (ripasudil, %) | 3 (10.0) |
| Previous intraocular surgeries, eyes (%) | |
| Cataract surgery | 8 (26.7) |
| Trabeculotomy | 2 (6.7) |
| Laser trabeculoplasty | 3 (10.0) |
Unless otherwise indicated, data are expressed as the mean ± standard deviation (interquartile range). POAG, primary open-angle glaucoma; XFG, exfoliation glaucoma.
Figure 1.Representative OCT and LSFG images in the macula of the same eye at different time points. (Left) Horizontal OCT b scan images showing the area of CT measurements (width of 1500 µm centered on the fovea). The demarcated regions represent the choroidal stromal area, and the area outside the demarcated regions represents the choroidal vascular area. (Right) Color-coded MBR maps of LSFG. Square measurement regions (300 × 300 pixels) were set in the central macula. Measurements in postoperative OCT and LSFG images were performed at the same retinal location as the baseline. The mCT in both mCVT and mCIT and MBR increased at all postoperative time points.
Figure 2.Longitudinal changes in the various parameters. Measurements were performed at baseline and 1, 3, and 6 months postoperatively. (A) IOP (mm Hg). (B) MAP (mm Hg). (C) OPP (mm Hg). (D) Pulse rate (beats/min). (E) AL (mm). (F) MBR (AU). G: mCT (µm). (H) mCVT(µm). (I) mCIT (µm). The estimated marginal means ± standard error were derived from mixed-effects models with patient-specific random intercepts and slopes, accounting for repeated measurements. Differences in the timing of the OCT measurement from baseline were entered into the models as a possible confounder. *Bonferroni-corrected P < .05 compared with baseline values.
Baseline Values and Postoperative Changes of Various Parameters After Trabeculectomy
| Baseline | 1 Month | 3 Months | 6 Months |
| |
|---|---|---|---|---|---|
| IOP, mm Hg | 18.0 ± 4.6 (15 − 20) | −8.5 ± 0.9 (−45.0 ± 3.9%) | −9.7 ± 0.9 (−51.3± 3.6%) | -9.5 ± 0.9 (−50.3 ± 3.4%) | <0.001, <0.001, <0.001 |
| MAP, mm Hg | 90.0 ± 15.7 (80–102) | +5.9 ± 2.4 (+7.4 ± 2.8%) | +3.1 ± 2.6 (+5.1 ± 2.8%) | +5.2 ± 3.3 (+8.0 ± 3.7%) | 0.08, 1.0, 0.69 |
| OPP, mm Hg | 42.0 ± 10.7 (34–49) | +12.6 ± 1.9 (+34.2 ± 6.0%) | +12.0 ± 2.0 (+34.8 ± 5.6%) | +12.8 ± 2.3 (+37.5 ± 6.5%) | <0.001, <0.001, <0.001 |
| Pulse rate, beats/min | 72.5 ± 11.5 (63–82) | +2.2 ± 1.9 (+3.9 ± 2.8%) | +0.7 ± 2.0 (+1.9 ± 2.8%) | 0.002 ± 2.0 (+0.8 ± 2.8%) | 1.0, 1.0, 1.0 |
| AL, mm | 24.1 ± 1.2 (23.3–25.2) | −0.12 ± 0.02 (−0.5 ± 0.1%) | −0.15 ± 0.02 (−0.6 ± 0.1%) | −0.19 ± 0.02 (−0.8 ± 0.1%) | <0.001, <0.001, <0.001 |
| mCT, µm | 196.3 ± 63.5 (147.3–235.4) | +31.1 ± 5.5 (+16.1 ± 3.0%) | +37.4 ± 5.4 (+19.2 ± 2.9%) | +35.4 ± 5.3 (+18.9 ± 2.8%) | <0.001, <0.001, <0.001 |
| mCVT, µm | 138.5 ± 44.8 (107.0–169.5) | +21.4 ± 4.2 (+15.6 ± 3.2%) | +26.2 ± 4.1 (+19.4 ± 3.1%) | +25.2 ± 4.1 (+19.9 ± 3.1%) | <0.001, <0.001, <0.001 |
| mCIT, µm | 57.7 ± 21.8 (40.3–68.7) | +9.9 ± 2.0 (+18.2 ± 3.7%) | +11.2 ± 2.0 (+19.7 ± 3.4%) | +10.1 ± 2.0 (+17.3 ± 2.9%) | <0.001, <0.001, <0.001 |
| MBR, AU | 9.0 ± 3.9 (6.4–11.1) | +1.9 ± 0.3 (+22.1 ± 5.5%) | +1.6 ± 0.3 (+24.9 ± 5.4%) | +1.4 ± 0.4 (+21.6 ± 5.3%) | <0.001, <0.001, <0.001 |
| Differences in OCT measurement time of the day from baseline (h) | NA | −5.0 ± 0.5 | −4.7 ± 0.5 | −3.9 ± 0.5 | <0.001, <0.001, <0.001 |
Baseline values are shown as the mean ± standard deviation (interquartile range). Postoperative changes were examined with mixed-effects models with patient-specific random intercepts and slopes accounting for repeated measurements, and are shown as estimated marginal means ± standard error. Differences in OCT measurement time of the day from baseline was entered into the models as a possible confounder. P values were adjusted for multiple comparisons by the Bonferroni correction.
AU, arbitrary unit; NA, not applicable.
Figure 3.Scatter plots showing the relationship between two variables of postoperative changes (%). All data at 1, 3, and 6 months are combined. (A–E) AL, mCT, mCVT, mCIT, and MBR changes (%) versus IOP changes (%), respectively. (F–J) AL, mCT, mCVT, mCIT, and MBR changes (%) versus OPP changes (%), respectively. (K–N) mCT, mCVT, mCIT, and MBR changes (%) versus AL changes (%), respectively. (O–Q) mCT, mCVT, and mCIT changes (%) versus MBR changes (%), respectively. P values are derived from univariate mixed-effects models with patient-specific random intercepts and slopes accounting for repeated measurements. Differences in the timing of the OCT measurement from baseline were entered into the models as a possible confounder. The dotted line indicates a regression line in each graph.
Univariate Analysis of Various Factors for Postoperative Changes of mCT, mCVT, mCIT, and MBR
| mCT Change (%) | mCVT Change (%) | mCIT Change (%) | MBR Change (%) | |
|---|---|---|---|---|
| Independent Variables | Coefficient (SE), | Coefficient (SE), | Coefficient (SE), | Coefficient (SE), |
| Baseline values of dependent variable, µm or AU | −0.02 (0.04), 0.61 | −0.07 (0.06), 0.30 | 0.06 (0.14), 0.68 | −3.2 (1.0), 0.002 |
| Sex, male vs. female | 14.3 (4.9), 0.004 | 14.2 (5.4), 0.009 | 13.2 (5.6), 0.02 | 18.4 (8.7), 0.03 |
| Glaucoma type, POAG vs. XFG | −6.9 (6.5), 0.28 | −9.6 (7.0), 0.17 | 0.9 (7.2), 0.90 | −13.1 (10.7), 0.22 |
| Age, years | 0.40 (0.29), 0.17 | 0.42 (0.32), 0.196 | 0.32 (0.32), 0.31 | 0.12, (0.51), 0.81 |
| Systemic hypertension | −6.6 (5.2), 0.202 | −6.0 (5.7), 0.29 | −5.9 (5.7), 0.31 | 7.9 (8.8), 0.37 |
| Baseline AL, mm | 1.1 (2.3), 0.63 | 0.33 (2.5), 0.89 | 1.9 (2.4), 0.44 | −7.0 (3.6), 0.051 |
| AL change, (%) | −5.6 (2.6), 0.03 | −6.8 (2.9), 0.02 | −3.5 (3.4), 0.30 | −0.16 (6.7), 0.98 |
| Baseline PR, beats/min | −0.23 (0.23), 0.31 | −0.25 (0.25), 0.31 | −0.18 (0.25), 0.47 | 0.26 (0.38), 0.49 |
| PR change (%) | 0.11 (0.09), 0.22 | 0.11 (0.09), 0.22 | 0.14 (0.11), 0.18 | −0.06 (0.21), 0.78 |
| Baseline mean deviation, dB | −0.42 (0.47), 0.37 | −0.41 (0.51), 0.42 | −0.32 (0.51), 0.52 | −0.70 (0.78), 0.37 |
| Preoperative medication score | −7.4 (3.3), 0.02 | −6.3 (3.7), 0.09 | −9.4 (3.5), 0.007 | −5.5 (5.9), 0.35 |
| Preoperative brimonidine | −16.8 (5.9), 0.004 | −18.1 (6.4), 0.005 | −16.1 (6.9), 0.02 | −28.3 (9.7), 0.003 |
| Preoperative bunazosin | 6.2 (5.5), 0.26 | 6.3 (6.0), 0.30 | 4.5 (6.1), 0.46 | 3.2 (9.3), 0.74 |
| Pseudophakia | 3.0 (6.0), 0.61 | 4.2 (6.5), 0.52 | 3.4 (6.5), 0.60 | 9.9 (9.8), 0.31 |
| Differences in OCT measurement time of the day from baseline (h) | 0.64 (0.54), 0.23 | 0.51 (0.60), 0.40 | 0.14 (0.85), 0.87 | −1.8 (1.3), 0.16 |
| Baseline IOP (mm Hg) | 1.2 (0.5), 0.02 | 1.6 (0.6), 0.005 | 0.60 (0.63), 0.34 | 1.6 (0.9), 0.08 |
| IOP change (%) | −0.20 (0.07), 0.005 | −0.21 (0.08), 0.009 | −0.20 (0.09), 0.03 | −0.28 (0.17), 0.10 |
| MAP change (%) | 0.12 (0.10), 0.24 | 0.21 (0.11), 0.045 | −0.08 (0.12), 0.48 | 0.49 (0.23), 0.04 |
| Baseline OPP (mm Hg) | −0.25 (0.25), 0.32 | −0.35 (0.27), 0.19 | 0.11 (0.27), 0.68 | −0.58 (0.40), 0.15 |
| OPP change (%) | 0.14 (0.06), 0.01 | 0.21 (0.06), 0.001 | 0.07 (0.08), 0.39 | 0.36 (0.13), 0.005 |
| Baseline mCT (µm) | −0.02 (0.04), 0.61 | −0.03 (0.05), 0.55 | 0.01 (0.05), 0.81 | 0.14 (0.07), 0.052 |
| mCT change (%) | NA | 1.05 (0.04), <0.001 | 0.89 (0.09), <0.001 | 0.85 (0.22), <0.001 |
| mCVT change (%) | 0.86 (0.03), <0.001 | NA | 0.53 (0.11), <0.001 | 0.85 (0.19), <0.001 |
| mCIT change (%) | 0.62 (0.06), <0.001 | 0.46 (0.09), <0.001 | NA | 0.31 (0.21), 0.13 |
| Baseline MBR (AU) | −1.1 (0.7), 0.08 | −1.3 (0.7), 0.08 | −0.79 (0.74), 0.29 | −3.2 (1.0), 0.002 |
| MBR change (%) | 0.17 (0.05), <0.001 | 0.21 (0.05), <0.001 | 0.10 (0.06), 0.11 | NA |
The coefficients and P value values were derived from univariate mixed-effects models with patient-specific random intercepts and slopes accounting for repeated measurements. Differences in OCT measurement time of the day from baseline was entered into the models as a possible confounder. AU, arbitrary unit; NA, not applicable; POAG, primary open-angle glaucoma; PR, pulse rate; SE, standard error; XFG, exfoliation glaucoma.
Multivariate Analysis of Various Factors for Postoperative Changes of mCT, mCVT, and mCIT
| mCT Change (%) | mCVT Change (%) | mCIT Change (%) | |
|---|---|---|---|
| Independent Variables | Coefficient (SE), | Coefficient (SE), | Coefficient (SE), |
| Baseline values of dependent variable, µm | −0.11 (0.04), 0.01 | ||
| Sex, male vs. female | 10.8 (4.0), 0.007 | 10.4 (3.8), 0.007 | |
| Glaucoma type, POAG vs. XFG | |||
| Age, years | |||
| Systemic hypertension | |||
| Baseline AL, mm | |||
| AL change, (%) | −7.5 (3.3), 0.02 | ||
| Baseline PR, beats/min | |||
| PR change (%) | |||
| Baseline mean deviation, dB | |||
| Preoperative medication score | −7.9 (3.1), 0.01 | ||
| Preoperative brimonidine | |||
| Preoperative bunazosin | |||
| Pseudophakia | |||
| Differences in OCT measurement time of the day from baseline (hour) | 0.85 (0.60), 0.16* | 0.70 (0.61), 0.25* | 0.84 (0.83), 0.31* |
| Baseline IOP (mm Hg) | |||
| IOP change (%) | −0.20 (0.08), 0.008* | NA | −0.28 (0.10), 0.005* |
| MAP change (%) | 0.08 (0.09), 0.36* | NA | −0.10 (0.11), 0.38* |
| Baseline OPP (mm Hg) | |||
| OPP change (%) | NA | 0.11 (0.05), 0.035* | NA |
| Baseline MBR (AU) | |||
| MBR change (%) | 0.13 (0.05), 0.01* | 0.21 (0.05), <0.001 * | 0.05 (0.07), 0.41* |
The coefficients and P values are derived from multivariate mixed-effects models with patient-specific random intercepts and slopes accounting for repeated measurements Differences in OCT measurement time of the day from baseline was entered into the models as a possible confounder. Independent variables with P <0.2 in the univariate analysis and variables marked with * were entered into the multivariate model. The final model was created by backward elimination. Variables marked with * were retained in the model regardless of the P values. AU, arbitrary unit; NA, not applicable; POAG, primary open-angle glaucoma; PR, pulse rate; SE, standard error; XFG, exfoliation glaucoma.
Multivariate Analysis of Various Factors for Postoperative Changes of MBR
| MBR Change (%) | MBR Change (%) | MBR Change (%) | |
|---|---|---|---|
| Model A | Model B | Model C | |
| Independent Variables | Coefficient (SE), | Coefficient (SE), | Coefficient (SE), |
| Baseline values of dependent variable, AU | −3.0 (0.8), <0.001 | −2.8 (0.8), <0.001 | −3.0 (0.7), <0.001 |
| Sex, male vs. female | |||
| Glaucoma type, POAG vs. XFG | |||
| Age, years | |||
| Systemic hypertension | |||
| Baseline AL, mm | |||
| AL change, (%) | |||
| Baseline PR, beats/min | |||
| PR change (%) | |||
| Baseline mean deviation, dB | |||
| Preoperative medication score | |||
| Preoperative brimonidine | −20.5 (7.9), 0.01 | ||
| Preoperative bunazosin | |||
| Pseudophakia | |||
| Differences in OCT measurement time of the day from baseline (h) | −3.5 (1.3), 0.006* | −3.4 (1.2), 0.006* | −3.2 (1.3), 0.014* |
| Baseline IOP (mm Hg) | |||
| Baseline OPP (mm Hg) | |||
| OPP change (%) | 0.31 (0.10), 0.002* | 0.25 (0.10), 0.01* | 0.39 (0.09), <0.001* |
| Baseline mCT (µm) | 0.18 (0.05), <0.001 | 0.18 (0.05), <0.001 | 0.17 (0.05), 0.001 |
| mCT change (%) | 0.66 (0.21), 0.002* | NA | NA |
| mCVT change (%) | NA | 0.73 (0.20), <0.001* | NA |
| mCIT change (%) | NA | NA | 0.15 (0.17), 0.39* |
| AIC/BIC | 524.9/ 545.5 | 521.9/ 542.5 | 527.4/ 550.1 |
The coefficients and P values are derived from multivariate mixed-effects models with patient-specific random intercepts and slopes accounting for repeated measurements. Differences in OCT measurement time of day from baseline was entered into the models as a possible confounder. mCT, mCVT or mCIT were entered individually into models A, B, or C, respectively. Independent variables with P <0.2 in the univariate analysis and variables marked with * were entered into the multivariate model. Final model was created by backward elimination. Variables marked with * were retained in the model regardless of the P values. AIC and BIC are shown to indicate the model with optimal balance of model fit and model complexity.
AIC, Akaike information criterion; AU, arbitrary unit; BIC, Bayesian information criterion; NA, not applicable; POAG, primary open angle glaucoma; PR, pulse rate; SE, standard error; XFG, exfoliation glaucoma.